MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/v17020274

Медицинская библиотека · Viruses · 2025

Effect of Secondary Infections on the Outcomes of Patients with Hematological Malignancies and SARS-CoV-2 Infection: Results from the HM-COV 3.0 Study.

Petrucci Flavia, Pellicano Chiara, Cogliati Dezza Francesco, Valeri Serena, Covino Sara, Iannazzo Francesco, Infante Francesca, Gigante Antonietta, Sacco Federica, Viscido Agnese, Iacovelli Alessandra, Rosato Edoardo, Palange Paolo, Mastroianni Claudio Maria, Oliva Alessandra

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Patients with hematological malignancies (HMs) are at higher risk of severe COVID-19 and secondary infections, which further complicate their outcomes. This study evaluated the impact of secondary infections (SIs) on mortality in hospitalized HM patients with SARS-CoV-2 infection and identified risk factors associated with SIs. We included 217 patients with HMs and COVID-19 admitted to a tertiary hospital in Rome, from April 2020 to September 2022. SIs occurred in 44.2% of patients, with bloodstream infections (42.7%) and respiratory infections (30.5%) being most frequent; among the latter, COVID-19-associated pulmonary aspergillosis (CAPA) was observed in 41.4% of cases. Viral reactivations, predominantly CMV, occurred in 9.2% of patients. The overall mortality rate was 29%, with higher mortality observed in patients with SIs (47.4% vs. 14.7%, p < 0.01). Risk factors for SIs included severe COVID-19 (OR = 2.957, p < 0.05) and prolonged hospitalization (OR = 1.095, p < 0.001). Severe COVID-19 (OR = 8.229, p < 0.001), intensive care unit (ICU) admission (OR = 15.232, p < 0.001), chronic steroid therapy (OR = 2.803, p < 0.05), SIs (OR = 2.892, p < 0.05), and viral reactivation (OR = 6.269, p < 0.01) were independent predictors of mortality. SIs and viral reactivations are common in patients with HMs and SARS-CoV-2 infection and significantly increase mortality, highlighting the need for timely management and preventive strategies in this vulnerable population.

Для цитирования: Petrucci Flavia, Pellicano Chiara, Cogliati Dezza Francesco, Valeri Serena, Covino Sara, Iannazzo Francesco, Infante Francesca, Gigante Antonietta, Sacco Federica, Viscido Agnese, Iacovelli Alessandra, Rosato Edoardo, Palange Paolo, Mastroianni Claudio Maria, Oliva Alessandra. Effect of Secondary Infections on the Outcomes of Patients with Hematological Malignancies and SARS-CoV-2 Infection: Results from the HM-COV 3.0 Study.. Viruses. 2025. DOI: 10.3390/v17020274.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.